Patents by Inventor Daniel John INGLIS

Daniel John INGLIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • READ REQUEST RESPONSE FOR RECONSTRUCTED DATA IN A DEGRADED DRIVE
    Publication number: 20240152426
    Abstract: A method comprising: receiving a request to read data stored in an array of drives; determining that the data is stored on one or more degraded drives in the array; reconstructing the data from one or more drives in the array other than the degraded drives; providing the reconstructed data in response to the request; and after providing the reconstructed data, writing the reconstructed data to one or more drives in the array other than the degraded drives.
    Type: Application
    Filed: January 11, 2024
    Publication date: May 9, 2024
    Inventors: Stuart John Inglis, Sheridan John Lambert, Adam Gworn Kit Fleming, Daniel James Nicholas Stokes
  • Affinity-based cache operation for a persistent storage device
    Patent number: 11914519
    Abstract: Aspects described herein relate to a method comprising: receiving a request to write data to a persistent storage device, the request comprising data; determining an affinity of the data; writing the request to a cache line of a cache; associating the cache line with the affinity of the data; and reporting the data as having been written to the persistent storage device.
    Type: Grant
    Filed: January 21, 2022
    Date of Patent: February 27, 2024
    Assignee: Nyriad, Inc.
    Inventors: Stuart John Inglis, Cameron Ray Simmonds, Dmitry Lapik, Chia-Chi Hsu, Daniel James Nicholas Stokes, Adam Gworn Kit Fleming
  • Antibody and checkpoint inhibitor combination therapy
    Patent number: 11655304
    Abstract: The present invention provides a combination therapy for treatment of a tumour in a subject. The combination therapy comprises administration of (i) an antibody directed against cancer stem cells and (ii) a checkpoint inhibitor.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: May 23, 2023
    Assignee: Bionomics Limited
    Inventors: Tina Christine Lavranos, Daniel John Inglis, Christopher L. Reyes
  • ANTIBODY AND CHECKPOINT INHIBITOR COMBINATION THERAPY
    Publication number: 20190263925
    Abstract: The present invention provides a combination therapy for treatment of a tumour in a subject. The combination therapy comprises administration of (i) an antibody directed against cancer stem cells and (ii) a checkpoint inhibitor.
    Type: Application
    Filed: September 14, 2017
    Publication date: August 29, 2019
    Inventors: Tina Christine LAVRANOS, Daniel John INGLIS, Christopher L. REYES